These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 868850)

  • 1. Long-term results in the treatment of regional ileitis with coherin.
    Hiatt RB; Goodman I
    Am J Gastroenterol; 1977 Mar; 67(3):274-7. PubMed ID: 868850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The physiologic properties and therapeutic potential of coherin.
    Hiatt RB; Goodman I
    Am J Surg; 1979 Jan; 137(1):82-6. PubMed ID: 758845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of coherin on patients with idiopathic delayed gastric emptying.
    Davidson ED; Hersh T; Perkel MS; Moore C; Fajman WA
    Am J Gastroenterol; 1980 Nov; 74(5):419-22. PubMed ID: 7015842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of coherin on the basic electrical rhythm of the dog ileum in vivo.
    Hiatt RB; Goodman I; Sandler B; Cheskin H
    Am J Dig Dis; 1977 Feb; 22(2):108-12. PubMed ID: 835551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of drug therapy for inflammatory bowel disease.
    Peppercorn MA
    Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of long-term low-dose prednisone on height velocity and disease activity in pediatric and adolescent patients with Crohn disease.
    Navarro FA; Hanauer SB; Kirschner BS
    J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):312-8. PubMed ID: 17873743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results with azathioprine therapy in patients with corticosteroid-dependent Crohn's disease: open-label prospective study.
    Chebli JM; Gaburri PD; De Souza AF; Pinto AL; Chebli LA; Felga GE; Forn CG; Pimentel CF
    J Gastroenterol Hepatol; 2007 Feb; 22(2):268-74. PubMed ID: 17295882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimycobacterial therapy in Crohn's disease: results of a controlled, double-blind trial with a multiple antibiotic regimen.
    Prantera C; Kohn A; Mangiarotti R; Andreoli A; Luzi C
    Am J Gastroenterol; 1994 Apr; 89(4):513-8. PubMed ID: 8147352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternate-day prednisone treatment and treatment maintenance in Crohn's disease.
    Bello C; Goldstein F; Thornton JJ
    Am J Gastroenterol; 1991 Apr; 86(4):460-6. PubMed ID: 1672787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental study on the use of intravenous immunoglobulin (IVIg) in patients with steroid-resistant Crohn's disease.
    Chrissafidou A; Malek M; Musch E
    Z Gastroenterol; 2007 Jul; 45(7):605-8. PubMed ID: 17620224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical decision making in family practice. A patient with abdominal pain and chills].
    Schippers EF; de Meijer PH; Meinders AE
    Ned Tijdschr Geneeskd; 1998 Jun; 142(26):1493-500. PubMed ID: 9752068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levamisole in Crohn's disease: a randomized, double-blind, placebo-controlled clinical trial.
    Sachar DB; Rubin KP; Gumaste V
    Am J Gastroenterol; 1987 Jun; 82(6):536-9. PubMed ID: 3554991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
    Dejaco C; Gasché C; Reinisch W; Moser G; Novacek G; Tillinger W; Vogelsang H; Gangl A
    Wien Klin Wochenschr; 1998 Sep; 110(16):579-84. PubMed ID: 9782579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug treatment of Crohn's disease].
    van Deventer SJ; Tytgat GN
    Ned Tijdschr Geneeskd; 1998 May; 142(21):1191-5. PubMed ID: 9627451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide treatment of postgastrectomy obstruction.
    Hiatt RB; Goodman I
    Arch Surg; 1976 Sep; 111(9):997-9. PubMed ID: 949264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sick building syndrome (SBS) and exposure to water-damaged buildings: time series study, clinical trial and mechanisms.
    Shoemaker RC; House DE
    Neurotoxicol Teratol; 2006; 28(5):573-88. PubMed ID: 17010568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss.
    Battaglia A; Burchette R; Cueva R
    Otol Neurotol; 2008 Jun; 29(4):453-60. PubMed ID: 18401285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic possibilities and results in regional ileitis].
    Demole M; Sayegh C; Soualili EH
    Praxis; 1965 Nov; 54(47):1402-6. PubMed ID: 5899381
    [No Abstract]   [Full Text] [Related]  

  • 20. [Better to start from top?].
    MMW Fortschr Med; 2005 Oct; 147(42):8. PubMed ID: 16281774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.